Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,762 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ADAMTS-13: A Prognostic Biomarker for Portal Vein Thrombosis in Japanese Patients with Liver Cirrhosis.
Suzuki J, Namisaki T, Takya H, Kaji K, Nishimura N, Shibamoto A, Asada S, Kubo T, Iwai S, Tomooka F, Takeda S, Koizumi A, Tanaka M, Matsuda T, Inoue T, Fujimoto Y, Tsuji Y, Fujinaga Y, Sato S, Kitagawa K, Kawaratani H, Akahane T, Mitoro A, Matsumoto M, Asada K, Yoshiji H. Suzuki J, et al. Among authors: takeda s. Int J Mol Sci. 2024 Feb 26;25(5):2678. doi: 10.3390/ijms25052678. Int J Mol Sci. 2024. PMID: 38473925 Free PMC article.
Rifaximin enhances the L‑carnitine‑mediated preventive effects on skeletal muscle atrophy in cirrhotic rats by modulating the gut‑liver‑muscle axis.
Murata K, Kaji K, Nishimura N, Enomoto M, Fujimoto Y, Takeda S, Tsuji Y, Fujinaga Y, Takaya H, Kawaratani H, Namisaki T, Akahane T, Yoshiji H. Murata K, et al. Among authors: takeda s. Int J Mol Med. 2022 Aug;50(2):101. doi: 10.3892/ijmm.2022.5157. Epub 2022 Jun 10. Int J Mol Med. 2022. PMID: 35686541 Free PMC article.
Macrophage Activation Markers Predict Liver-Related Complications in Primary Biliary Cholangitis.
Fujinaga Y, Namisaki T, Tsuji Y, Suzuki J, Murata K, Takeda S, Takaya H, Inoue T, Noguchi R, Fujimoto Y, Enomoto M, Nishimura N, Kitagawa K, Kaji K, Kawaratani H, Akahane T, Mitoro A, Yoshiji H. Fujinaga Y, et al. Among authors: takeda s. Int J Mol Sci. 2022 Aug 29;23(17):9814. doi: 10.3390/ijms23179814. Int J Mol Sci. 2022. PMID: 36077228 Free PMC article.
Changes in Coagulation and Fibrinolytic Factors in Patients With Cirrhotic Refractory Ascites Undergoing Cell-free and Concentrated Ascites Reinfusion Therapy: A Retrospective Observational Study in Japan.
Yorioka N, Namisaki T, Shibamoto A, Suzuki J, Kubo T, Iwai S, Tomooka F, Tanaka M, Takeda S, Fujimoto Y, Enomoto M, Muarata K, Inoue T, Tsuji Y, Fujinaga Y, Nishimura N, Kitagawa K, Takaya H, Kaji K, Kawaratani H, Akahane T, Mitoro A, Yamazaki M, Yoshiji H. Yorioka N, et al. Among authors: takeda s. In Vivo. 2023 May-Jun;37(3):1226-1235. doi: 10.21873/invivo.13199. In Vivo. 2023. PMID: 37103093 Free PMC article.
VWF/ADAMTS13 Ratio as a Potential Predictive Biomarker for Acute Kidney Injury Onset in Cirrhosis.
Asada S, Namisaki T, Kaji K, Takaya H, Kubo T, Akahane T, Kawaratani H, Nishimura N, Takeda S, Masuda H, Shibamoto A, Inoue T, Iwai S, Tomooka F, Tsuji Y, Fujinaga Y, Kitagawa K, Mitoro A, Sato S, Matsumoto M, Yoshiji H. Asada S, et al. Among authors: takeda s. Dig Dis Sci. 2024 Mar;69(3):851-869. doi: 10.1007/s10620-023-08257-w. Epub 2024 Jan 20. Dig Dis Sci. 2024. PMID: 38244124
The association between sarcopenia and endotoxin in patients with alcoholic cirrhosis.
Sato S, Namisaki T, Murata K, Fujimoto Y, Takeda S, Enomoto M, Shibamoto A, Ishida K, Ogawa H, Takagi H, Tsuji Y, Kaya D, Fujinaga Y, Furukawa M, Inoue T, Sawada Y, Nishimura N, Kitagawa K, Ozutsumi T, Takaya H, Kaji K, Shimozato N, Kawaratani H, Moriya K, Akahane T, Mitoro A, Yoshiji H. Sato S, et al. Among authors: takeda s. Medicine (Baltimore). 2021 Sep 10;100(36):e27212. doi: 10.1097/MD.0000000000027212. Medicine (Baltimore). 2021. PMID: 34516526 Free PMC article.
Clinical Significance of Gamma-Glutamyltranspeptidase Combined with Carbohydrate-Deficient Transferrin for the Assessment of Excessive Alcohol Consumption in Patients with Alcoholic Cirrhosis.
Shibamoto A, Namisaki T, Suzuki J, Kubo T, Iwai S, Tomooka F, Takeda S, Fujimoto Y, Enomoto M, Murata K, Inoue T, Ishida K, Ogawa H, Takagi H, Kaya D, Tsuji Y, Ozutsumi T, Fujinaga Y, Furukawa M, Nishimura N, Sawada Y, Kitagawa K, Sato S, Takaya H, Kaji K, Shimozato N, Kawaratani H, Moriya K, Akahane T, Mitoro A, Yoshiji H. Shibamoto A, et al. Among authors: takeda s. Medicines (Basel). 2021 Jul 19;8(7):39. doi: 10.3390/medicines8070039. Medicines (Basel). 2021. PMID: 34357155 Free PMC article.
Enhanced liver fibrosis score as a surrogate of liver-related complications and mortality in primary biliary cholangitis.
Fujinaga Y, Namisaki T, Takaya H, Tsuji Y, Suzuki J, Shibamoto A, Kubo T, Iwai S, Tomooka F, Takeda S, Fujimoto Y, Enomoto M, Murata K, Ishida K, Ogawa H, Takagi H, Ozutsumi T, Furukawa M, Nishimura N, Sawada Y, Kitagawa K, Sato S, Kaji K, Kawaratani H, Moriya K, Noguchi R, Akahane T, Mitoro A, Yoshiji H. Fujinaga Y, et al. Among authors: takeda s. Medicine (Baltimore). 2021 Oct 1;100(39):e27403. doi: 10.1097/MD.0000000000027403. Medicine (Baltimore). 2021. PMID: 34596167 Free PMC article.
The Combination of Albumin-Bilirubin Score and Prothrombin Time Is a Useful Tool for Predicting Liver Dysfunction after Transcatheter Arterial Chemoembolization in Child-Pugh Class A Patients with Hepatocellular Carcinoma within Up-to-Seven Criteria.
Takaya H, Namisaki T, Takeda S, Kaji K, Ogawa H, Ishida K, Tsuji Y, Takagi H, Ozutsumi T, Fujinaga Y, Furukawa M, Kitagawa K, Nishimura N, Sawada Y, Shimozato N, Kawaratani H, Moriya K, Akahane T, Mitoro A, Yoshiji H. Takaya H, et al. Among authors: takeda s. J Clin Med. 2021 Oct 21;10(21):4838. doi: 10.3390/jcm10214838. J Clin Med. 2021. PMID: 34768358 Free PMC article.
3,762 results